We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+24.97%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$111B
AUM Growth
+$14.9B
Cap. Flow
-$1.95B
Cap. Flow %
-1.76%
Top 10 Hldgs %
40.37%
Holding
493
New
5
Increased
168
Reduced
169
Closed
39

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$710M
2
IOT icon
Samsara
IOT
+$298M
3
MRNA icon
Moderna
MRNA
+$277M
4
SEDG icon
SolarEdge
SEDG
+$272M
5
POOL icon
Pool Corp
POOL
+$234M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.82%
2 Healthcare 22.38%
3 Technology 21.54%
4 Communication Services 11.88%
5 Financials 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
426
Alibaba
BABA
$308B
$3.98K ﹤0.01%
39
+10
+34% +$1K
AI icon
427
C3.ai
AI
$1.59B
$3.93K ﹤0.01%
117
VUZI icon
428
Vuzix
VUZI
$224M
$3.83K ﹤0.01%
924
VERI icon
429
Veritone
VERI
$122M
$3.78K ﹤0.01%
649
FSLY icon
430
Fastly Inc
FSLY
$3.66B
$3.64K ﹤0.01%
205
ASXC
431
DELISTED
Asensus Surgical, Inc.
ASXC
$3.5K ﹤0.01%
5,338
BLNK icon
432
Blink Charging
BLNK
$87.9M
$3.42K ﹤0.01%
396
TSVT
433
DELISTED
2seventy bio
TSVT
$2.92K ﹤0.01%
286
BLUE
434
DELISTED
bluebird bio
BLUE
$2.73K ﹤0.01%
43
HCSG icon
435
Healthcare Services Group
HCSG
$1.53B
$2.18K ﹤0.01%
157
MASS icon
436
908 Devices
MASS
$364M
$2.14K ﹤0.01%
249
FATE icon
437
Fate Therapeutics
FATE
$326M
$2.12K ﹤0.01%
372
MARA icon
438
Marathon Digital Holdings
MARA
$3.9B
$1.74K ﹤0.01%
200
ICPT
439
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.36K ﹤0.01%
101
SRNE
440
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.34K ﹤0.01%
3,711
CGNT icon
441
Cognyte Software
CGNT
$680M
$1.25K ﹤0.01%
369
NVTA
442
DELISTED
Invitae Corporation
NVTA
$1.08K ﹤0.01%
800
DMTK
443
DELISTED
DermTech, Inc. Common Stock
DMTK
$1.05K ﹤0.01%
286
NKTR icon
444
Nektar Therapeutics
NKTR
$2.58B
$967 ﹤0.01%
92
NVAX icon
445
Novavax
NVAX
$1.31B
$901 ﹤0.01%
130
SEER icon
446
Seer Inc
SEER
$120M
$861 ﹤0.01%
223
CCSI icon
447
Consensus Cloud Solutions
CCSI
$647M
$818 ﹤0.01%
24
GAN
448
DELISTED
GAN Ltd
GAN
$738 ﹤0.01%
572
TSP
449
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$513 ﹤0.01%
349
HRTX icon
450
Heron Therapeutics
HRTX
$92.9M
$465 ﹤0.01%
308

Similar funds

Baillie Gifford & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Baillie Gifford & Co held 493 positions worth $111B, up 15% from $96B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Baillie Gifford & Co's Q1 2023 filing shows 5 new, 168 increased, 169 reduced and 39 closed positions. Its largest new stake was Samsara: 18,813,062 shares worth $371M. The largest sale was Salesforce, an estimated $439M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q1 2023 buy was Samsara: 18,813,062 shares worth $371M.
  • Baillie Gifford & Co added most to Advanced Micro Devices in Q1 2023, an estimated $710M increase.
  • Baillie Gifford & Co's biggest Q1 2023 reduction was Illumina, cutting an estimated $351M.
  • Baillie Gifford & Co fully exited Salesforce in Q1 2023, selling an estimated $439M.
  • Baillie Gifford & Co's ten largest holdings make up 40% of its $111B portfolio in Q1 2023.
  • Baillie Gifford & Co opened 5 new positions and closed 39 in Q1 2023.
  • Baillie Gifford & Co's portfolio value rose 15% quarter-over-quarter to $111B.

Based on Baillie Gifford & Co's 13F filing for Q1 2023, filed 3 May 2023.